Abstract:The Hippo pathway, initially identified through screenings for mutant tumor suppressors in Drosophila, is an evolutionarily conserved signaling pathway that controls organ size by regulating cell proliferation and apoptosis. Abnormal regulation of the Hippo pathway may lead to cancer in mammals. As the major downstream effectors of the Hippo pathway, unphosphorylated Yes-associated protein (YAP) and its homolog transcriptional co-activator TAZ (also called WWTR1) (hereafter called YAP/TAZ) are translocated into the nucleus. In the nucleus, in order to induce target gene expression, YAP/TAZ bind to the TEA domain (TEAD) proteins, and this binding subsequently promotes cell proliferation and inhibits apoptosis. In contrast, as key regulators of tumorigenesis and development, YAP/TAZ are phosphorylated and regulated by multiple molecules and pathways including Lats1/2 of Hippo, Wnt and G-protein-coupled receptor (GPCR) signaling, with a regulatory role in cell physiology, tumor cell development and pathological abnormalities simultaneously. In particular, the crucial role of YAP/TAZ in tumors ensures their potential as targets in designing anticancer drugs. To date, mounting research has elucidated the suppression of YAP/TAZ via effective inhibitors, which significantly highlights their application in cancer treatment. In the present review, we focus on the functions of YAP/TAZ in cancer, discuss their potential as new therapeutic target for tumor treatment, and provide valuable suggestions for further study in this field.

YAP‐mediated crosstalk between the Wnt and Hippo signaling pathways (Review

YAP/TAZ for Cancer Therapy: Opportunities and Challenges (Review).

YAP/TAZ for cancer therapy: Opportunities and challenges (Review)

Integration of Mechanical and Chemical Signals by YAP and TAZ Transcription Coactivators.

Multifaceted regulation and functions of YAP/TAZ in tumors (Review).

The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: an Updated Version.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

YAP/TAZ: Molecular pathway and disease therapy

TEAD Mediates YAP-dependent Gene Induction and Growth Control

An overview of signaling pathways regulating YAP/TAZ activity

[Crosstalk of Hippo/YAP and Wnt/β-catenin Pathways].

Multifaceted Regulation and Functions of YAP/TAZ in Tumors (Review)

The role of Hippo/YAP1 in cancer-associated fibroblasts: literature review and future perspectives

Molecular mechanisms of the mammalian Hippo signaling pathway.

Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine

Inactivation of Yap Oncoprotein by the Hippo Pathway is Involved in Cell Contact Inhibition and Tissue Growth Control

Targeting the Hippo Pathway for Anti-cancer Therapies.

The Role of YAP Transcription Coactivator in Regulating Stem Cell Self-Renewal and Differentiation.

New insights into the ambivalent role of YAP/TAZ in human cancers

Both Tead-Binding and Ww Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein

Context-dependent transcriptional regulations of YAP/TAZ in cancer